Brian CPA - Miromatrix Medical CFO Fin
| MIRODelisted Stock | USD 1.49 0.22 12.87% |
Insider
Brian CPA is CFO Fin of Miromatrix Medical
| Age | 59 |
| Phone | 952 942 6000 |
| Web | https://www.miromatrix.com |
Miromatrix Medical Management Efficiency
The company has return on total asset (ROA) of (0.5584) % which means that it has lost $0.5584 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1354) %, meaning that it created substantial loss on money invested by shareholders. Miromatrix Medical's management efficiency ratios could be used to measure how well Miromatrix Medical manages its routine affairs as well as how well it operates its assets and liabilities.Miromatrix Medical currently holds 3.55 M in liabilities with Debt to Equity (D/E) ratio of 0.1, which may suggest the company is not taking enough advantage from borrowing. Miromatrix Medical has a current ratio of 8.91, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Miromatrix Medical's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Kristina Masson | Acrivon Therapeutics, Common | 44 | |
| Andreas EMBA | Molecular Partners AG | 58 | |
| Joseph CPA | Inhibikase Therapeutics | 62 | |
| Thomas Schwerzmann | Molecular Partners AG | N/A | |
| Roger Rush | Inhibikase Therapeutics | N/A | |
| Noel MBA | PepGen | 54 | |
| Deepika PharmD | Pmv Pharmaceuticals | 47 | |
| Paul MD | AN2 Therapeutics | 54 | |
| Andrew Slee | Protagenic Therapeutics | 74 | |
| Morgan Conn | Pharvaris BV | 55 | |
| Alexander Zurcher | Molecular Partners AG | 49 | |
| William BASc | NervGen Pharma Corp | 60 | |
| Erick MD | Acrivon Therapeutics, Common | 66 | |
| James JD | Eliem Therapeutics | 58 | |
| Jochen Knolle | Pharvaris BV | 74 | |
| Peng MD | Pharvaris BV | 46 | |
| Seth Lewis | Molecular Partners AG | N/A | |
| Crystal Mercado | Acrivon Therapeutics, Common | N/A | |
| , MBA | Molecular Partners AG | 51 | |
| Eric Easom | AN2 Therapeutics | 56 | |
| Patrick Amstutz | Molecular Partners AG | 49 | |
Management Performance
| Return On Equity | -1.14 | |||
| Return On Asset | -0.56 |
Miromatrix Medical Leadership Team
Elected by the shareholders, the Miromatrix Medical's board of directors comprises two types of representatives: Miromatrix Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Miromatrix. The board's role is to monitor Miromatrix Medical's management team and ensure that shareholders' interests are well served. Miromatrix Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Miromatrix Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Brian CPA, CFO Fin | ||
| Jeffrey Ross, CEO Director | ||
| James Douglas, CFO Sec | ||
| John Barry, VP RD | ||
| Tom Emig, VP Culture |
Miromatrix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Miromatrix Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.14 | |||
| Return On Asset | -0.56 | |||
| Operating Margin | (593.69) % | |||
| Current Valuation | 80.11 M | |||
| Shares Outstanding | 27.42 M | |||
| Shares Owned By Insiders | 23.95 % | |||
| Shares Owned By Institutions | 25.75 % | |||
| Number Of Shares Shorted | 11.66 K | |||
| Price To Book | 5.98 X | |||
| Price To Sales | 97.02 X |
Pair Trading with Miromatrix Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Miromatrix Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Miromatrix Medical will appreciate offsetting losses from the drop in the long position's value.Moving against Miromatrix Stock
| 0.85 | KO | Coca Cola Aggressive Push | PairCorr |
| 0.78 | BKRKY | Bank Rakyat | PairCorr |
| 0.77 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.76 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.74 | EC | Ecopetrol SA ADR Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Miromatrix Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Miromatrix Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Miromatrix Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Miromatrix Medical to buy it.
The correlation of Miromatrix Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Miromatrix Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Miromatrix Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Miromatrix Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Miromatrix Stock
If you are still planning to invest in Miromatrix Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Miromatrix Medical's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |